Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone

Annals of the New York Academy of Sciences

Volumn 1132, Issue , 2008, Pages 344-347

  Newsom Davis, John ^a   Cutter, Gary ^b   Wolfe, Gil I ^c   Kaminski, Henry J ^d   Jaretzki III, Alfred ^e   Minisman, Greg ^b   Aban, Inmaculada ^b   Conwit, Robin ^f  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NewYork Presbyterian Hospital   (United States)

^f NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Myasthenia gravis; Prednisone; Thymectomy

Indexed keywords

CHOLINERGIC RECEPTOR; PREDNISONE;

ANAMNESIS; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; MONOTHERAPY; MYASTHENIA GRAVIS; NEUROLOGIC DISEASE; QUALITY OF LIFE; STROKE; SURGICAL TECHNIQUE; THYMECTOMY;

EID: 45249121569     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1405.014     Document Type: Conference Paper

References (4)

1. Lanska, D.J. 1990. Indications for thymectomy in myasthenia gravis. Neurology 40 : 1828 1829.
2. Gronseth, G.S. & R.J. Barohn. 2000. Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 55 : 7 15.
3. Pascuzzi, R.M., H.B. Coslett & T.R. Johns. 1984. Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients. Ann. Neurol. 15 : 291 298.
4. Jaretzki, A., III., R.J. Barohn, R.M. Ernstoff, et al. 2000. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Ann. Thorac. Surg. 70 : 327 334.